Galina Glazko
Concepts (315)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 16 | 2019 | 232 | 3.010 |
Why?
| Gene Expression Profiling | 15 | 2021 | 1118 | 2.060 |
Why?
| Gene Regulatory Networks | 7 | 2019 | 124 | 1.920 |
Why?
| Databases, Genetic | 8 | 2017 | 102 | 1.650 |
Why?
| Evolution, Molecular | 10 | 2012 | 110 | 1.620 |
Why?
| Transcriptome | 6 | 2021 | 344 | 1.540 |
Why?
| Colonic Neoplasms | 3 | 2019 | 167 | 1.370 |
Why?
| RNA | 4 | 2016 | 185 | 1.300 |
Why?
| Sequence Analysis, RNA | 6 | 2019 | 102 | 1.030 |
Why?
| Proteome | 3 | 2021 | 168 | 1.010 |
Why?
| DNA | 9 | 2013 | 586 | 0.990 |
Why?
| Gene Expression | 6 | 2022 | 721 | 0.970 |
Why?
| Oligonucleotide Array Sequence Analysis | 10 | 2017 | 499 | 0.970 |
Why?
| Phylogeny | 9 | 2010 | 270 | 0.860 |
Why?
| Genes, p53 | 4 | 2013 | 65 | 0.850 |
Why?
| Systems Biology | 2 | 2011 | 33 | 0.830 |
Why?
| Genes, Neoplasm | 1 | 2019 | 37 | 0.750 |
Why?
| Signal Transduction | 5 | 2019 | 1846 | 0.730 |
Why?
| Software | 5 | 2017 | 281 | 0.720 |
Why?
| Nuclear Matrix | 4 | 2003 | 6 | 0.700 |
Why?
| Consensus | 1 | 2019 | 147 | 0.700 |
Why?
| Colonic Polyps | 1 | 2017 | 46 | 0.650 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 201 | 0.630 |
Why?
| Models, Genetic | 7 | 2008 | 204 | 0.590 |
Why?
| Adenoma | 1 | 2017 | 149 | 0.580 |
Why?
| Genes, X-Linked | 1 | 2014 | 9 | 0.550 |
Why?
| Computer Simulation | 6 | 2017 | 341 | 0.540 |
Why?
| Genetic Variation | 4 | 2009 | 261 | 0.510 |
Why?
| Primates | 2 | 2003 | 24 | 0.470 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2012 | 49 | 0.460 |
Why?
| Proteins | 4 | 2014 | 406 | 0.450 |
Why?
| Models, Statistical | 3 | 2012 | 267 | 0.450 |
Why?
| Tumor Suppressor Protein p53 | 3 | 2017 | 257 | 0.440 |
Why?
| Disease | 1 | 2011 | 28 | 0.420 |
Why?
| Azospirillum brasilense | 2 | 2022 | 4 | 0.420 |
Why?
| Genome, Viral | 3 | 2008 | 91 | 0.420 |
Why?
| Bacteriophages | 2 | 2007 | 11 | 0.410 |
Why?
| Animals | 25 | 2021 | 14801 | 0.410 |
Why?
| Phenotype | 5 | 2017 | 840 | 0.410 |
Why?
| Humans | 35 | 2021 | 52865 | 0.400 |
Why?
| Base Sequence | 9 | 2013 | 773 | 0.380 |
Why?
| Genome | 3 | 2013 | 71 | 0.370 |
Why?
| Algorithms | 4 | 2017 | 729 | 0.370 |
Why?
| Neoplasms | 3 | 2005 | 1258 | 0.360 |
Why?
| Principal Component Analysis | 2 | 2019 | 73 | 0.360 |
Why?
| Gene Expression Regulation | 6 | 2017 | 1147 | 0.350 |
Why?
| Proteomics | 3 | 2021 | 327 | 0.340 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 154 | 0.320 |
Why?
| Molecular Sequence Data | 8 | 2012 | 1053 | 0.320 |
Why?
| Germ-Line Mutation | 3 | 2005 | 67 | 0.310 |
Why?
| Cluster Analysis | 4 | 2017 | 263 | 0.310 |
Why?
| Chromosome Mapping | 2 | 2008 | 175 | 0.300 |
Why?
| Linkage Disequilibrium | 1 | 2005 | 50 | 0.290 |
Why?
| Time | 2 | 2003 | 34 | 0.290 |
Why?
| Biological Evolution | 1 | 2005 | 42 | 0.270 |
Why?
| Chromosomes | 2 | 2008 | 37 | 0.270 |
Why?
| Binding Sites | 4 | 2012 | 471 | 0.260 |
Why?
| Multivariate Analysis | 3 | 2017 | 698 | 0.260 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 896 | 0.260 |
Why?
| Mammals | 3 | 2002 | 53 | 0.250 |
Why?
| Sequence Analysis, DNA | 5 | 2007 | 288 | 0.250 |
Why?
| DNA, Intergenic | 1 | 2003 | 7 | 0.240 |
Why?
| Conserved Sequence | 1 | 2003 | 61 | 0.240 |
Why?
| Herbaspirillum | 1 | 2022 | 2 | 0.230 |
Why?
| Genomics | 3 | 2017 | 268 | 0.230 |
Why?
| Cecum | 2 | 2021 | 75 | 0.230 |
Why?
| Mutation | 5 | 2019 | 1428 | 0.230 |
Why?
| RNA, Messenger | 4 | 2019 | 1282 | 0.220 |
Why?
| Cell Cycle Proteins | 2 | 2017 | 194 | 0.220 |
Why?
| Cell Line, Tumor | 2 | 2017 | 1503 | 0.200 |
Why?
| Selection, Genetic | 3 | 2012 | 27 | 0.200 |
Why?
| Cell Nucleus | 2 | 2013 | 220 | 0.190 |
Why?
| Infant Formula | 1 | 2021 | 142 | 0.190 |
Why?
| RNA, Untranslated | 1 | 2019 | 15 | 0.190 |
Why?
| Nucleotides | 2 | 2002 | 19 | 0.190 |
Why?
| Reproducibility of Results | 4 | 2016 | 1326 | 0.190 |
Why?
| Sequence Alignment | 4 | 2007 | 157 | 0.180 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2013 | 58 | 0.180 |
Why?
| Ruminococcus | 1 | 2019 | 9 | 0.180 |
Why?
| Drosophila melanogaster | 2 | 2012 | 24 | 0.180 |
Why?
| Phosphoproteins | 2 | 2013 | 122 | 0.180 |
Why?
| Extracellular Matrix | 1 | 2019 | 122 | 0.180 |
Why?
| Starch | 1 | 2019 | 33 | 0.180 |
Why?
| Profilins | 1 | 2018 | 21 | 0.170 |
Why?
| Sample Size | 2 | 2015 | 47 | 0.170 |
Why?
| Pharmacogenetics | 1 | 2018 | 53 | 0.170 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 42 | 0.170 |
Why?
| Small Molecule Libraries | 1 | 2018 | 74 | 0.160 |
Why?
| Hyperplasia | 1 | 2017 | 120 | 0.160 |
Why?
| Neurodegenerative Diseases | 1 | 2018 | 80 | 0.160 |
Why?
| Nuclear Proteins | 3 | 2006 | 270 | 0.160 |
Why?
| Chromatin | 2 | 2012 | 143 | 0.160 |
Why?
| GTP-Binding Proteins | 1 | 2017 | 95 | 0.160 |
Why?
| Gene Amplification | 1 | 1997 | 58 | 0.160 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 84 | 0.160 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 95 | 0.160 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 146 | 0.160 |
Why?
| DNA Replication | 2 | 2016 | 148 | 0.160 |
Why?
| DNA Helicases | 2 | 2016 | 141 | 0.160 |
Why?
| Diet | 1 | 2021 | 612 | 0.160 |
Why?
| Lampreys | 2 | 2007 | 2 | 0.160 |
Why?
| Data Mining | 1 | 2017 | 37 | 0.150 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 134 | 0.150 |
Why?
| Colorectal Neoplasms | 1 | 2019 | 232 | 0.150 |
Why?
| Protein Interaction Maps | 1 | 2016 | 24 | 0.150 |
Why?
| Down-Regulation | 1 | 2017 | 402 | 0.150 |
Why?
| Protein Processing, Post-Translational | 1 | 2017 | 185 | 0.150 |
Why?
| Protein Interaction Mapping | 1 | 2016 | 46 | 0.150 |
Why?
| Models, Theoretical | 1 | 2017 | 198 | 0.140 |
Why?
| Up-Regulation | 1 | 2017 | 536 | 0.140 |
Why?
| Mice | 5 | 2020 | 6389 | 0.140 |
Why?
| Kidney | 1 | 2020 | 834 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2017 | 387 | 0.140 |
Why?
| Breast Neoplasms | 3 | 2021 | 1272 | 0.130 |
Why?
| Bacterial Proteins | 1 | 2019 | 471 | 0.130 |
Why?
| Likelihood Functions | 2 | 2005 | 63 | 0.130 |
Why?
| Lung Neoplasms | 1 | 2019 | 598 | 0.130 |
Why?
| Fossils | 2 | 2005 | 19 | 0.130 |
Why?
| Data Interpretation, Statistical | 2 | 2013 | 185 | 0.130 |
Why?
| Lymphocytes | 1 | 2014 | 174 | 0.130 |
Why?
| Adaptation, Physiological | 2 | 2012 | 103 | 0.130 |
Why?
| Activating Transcription Factor 1 | 1 | 2013 | 23 | 0.120 |
Why?
| RNA Stability | 1 | 2013 | 26 | 0.120 |
Why?
| RNA, Fungal | 1 | 2013 | 29 | 0.120 |
Why?
| Schizosaccharomyces pombe Proteins | 1 | 2013 | 38 | 0.120 |
Why?
| RNA, Antisense | 1 | 2012 | 10 | 0.120 |
Why?
| Schizosaccharomyces | 1 | 2013 | 55 | 0.120 |
Why?
| RNA, Double-Stranded | 1 | 2012 | 17 | 0.120 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 10 | 0.120 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 138 | 0.120 |
Why?
| Genomic Instability | 1 | 2013 | 92 | 0.120 |
Why?
| Ribosomal Proteins | 1 | 2012 | 30 | 0.120 |
Why?
| Tunica Intima | 1 | 2012 | 65 | 0.110 |
Why?
| Genes | 2 | 2004 | 40 | 0.110 |
Why?
| Carotid Arteries | 1 | 2012 | 92 | 0.110 |
Why?
| Chromosome Disorders | 1 | 2012 | 39 | 0.110 |
Why?
| Disease Progression | 3 | 2020 | 898 | 0.110 |
Why?
| Amino Acid Sequence | 4 | 2008 | 813 | 0.110 |
Why?
| G-Quadruplexes | 1 | 2013 | 77 | 0.110 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 167 | 0.110 |
Why?
| Species Specificity | 2 | 2005 | 227 | 0.110 |
Why?
| Rats | 3 | 2019 | 3599 | 0.110 |
Why?
| Protein Array Analysis | 1 | 2010 | 27 | 0.100 |
Why?
| Gene Transfer, Horizontal | 2 | 2007 | 9 | 0.100 |
Why?
| Plant Roots | 2 | 2022 | 39 | 0.100 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 2003 | 63 | 0.100 |
Why?
| Saccharomyces cerevisiae | 2 | 2013 | 208 | 0.100 |
Why?
| Ethanol | 1 | 2012 | 332 | 0.090 |
Why?
| Periodicity | 1 | 2008 | 34 | 0.090 |
Why?
| Bacteria | 2 | 2021 | 238 | 0.090 |
Why?
| Thermus thermophilus | 1 | 2008 | 1 | 0.090 |
Why?
| Siphoviridae | 1 | 2008 | 1 | 0.090 |
Why?
| Bayes Theorem | 2 | 2012 | 124 | 0.080 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2008 | 103 | 0.080 |
Why?
| Viral Proteins | 2 | 2008 | 169 | 0.080 |
Why?
| Cell Proliferation | 1 | 2012 | 1124 | 0.080 |
Why?
| Cytosine Deaminase | 1 | 2007 | 5 | 0.080 |
Why?
| Male | 8 | 2020 | 28240 | 0.080 |
Why?
| Receptors, Antigen | 1 | 2007 | 2 | 0.080 |
Why?
| Flow Cytometry | 1 | 2010 | 582 | 0.080 |
Why?
| Globins | 3 | 2003 | 16 | 0.080 |
Why?
| Aryldialkylphosphatase | 1 | 2007 | 4 | 0.080 |
Why?
| DNA, Viral | 1 | 2008 | 152 | 0.080 |
Why?
| Amino Acid Substitution | 2 | 2004 | 110 | 0.080 |
Why?
| Nuclear Envelope | 1 | 2006 | 5 | 0.080 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2007 | 82 | 0.080 |
Why?
| Adaptation, Biological | 1 | 2005 | 10 | 0.070 |
Why?
| Receptors, Immunologic | 1 | 2005 | 38 | 0.070 |
Why?
| 5' Untranslated Regions | 2 | 2003 | 36 | 0.070 |
Why?
| Immunity | 1 | 2005 | 41 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2011 | 458 | 0.070 |
Why?
| Plants | 2 | 2002 | 53 | 0.070 |
Why?
| Pan troglodytes | 1 | 2005 | 14 | 0.070 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 60 | 0.070 |
Why?
| Hominidae | 1 | 2005 | 16 | 0.070 |
Why?
| Calibration | 1 | 2005 | 59 | 0.070 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 166 | 0.070 |
Why?
| Mutation, Missense | 1 | 2005 | 116 | 0.070 |
Why?
| DNA, Neoplasm | 1 | 2005 | 178 | 0.070 |
Why?
| Gene Expression Regulation, Archaeal | 1 | 2004 | 2 | 0.070 |
Why?
| Genes, Archaeal | 1 | 2004 | 4 | 0.070 |
Why?
| Chickens | 1 | 2005 | 123 | 0.070 |
Why?
| Eukaryotic Cells | 1 | 2004 | 17 | 0.070 |
Why?
| Octopamine | 1 | 2004 | 1 | 0.070 |
Why?
| Genes, Fungal | 1 | 2004 | 40 | 0.070 |
Why?
| Inheritance Patterns | 1 | 2004 | 24 | 0.070 |
Why?
| Statistics as Topic | 1 | 2004 | 108 | 0.060 |
Why?
| Genes, Bacterial | 1 | 2004 | 75 | 0.060 |
Why?
| CpG Islands | 1 | 2004 | 104 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2004 | 87 | 0.060 |
Why?
| Quality Control | 1 | 2004 | 98 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2007 | 569 | 0.060 |
Why?
| Membrane Proteins | 1 | 2006 | 395 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2004 | 145 | 0.060 |
Why?
| DNA Topoisomerases, Type I | 1 | 2003 | 3 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2020 | 1693 | 0.060 |
Why?
| DNA Topoisomerases, Type II | 1 | 2003 | 16 | 0.060 |
Why?
| Trans-Activators | 1 | 2004 | 162 | 0.060 |
Why?
| DNA Transposable Elements | 1 | 2003 | 96 | 0.060 |
Why?
| Dopamine | 1 | 2004 | 208 | 0.060 |
Why?
| Genome, Bacterial | 1 | 2004 | 151 | 0.060 |
Why?
| Immunoglobulins | 1 | 2003 | 87 | 0.060 |
Why?
| Vertebrates | 1 | 2002 | 12 | 0.060 |
Why?
| Myocardial Infarction | 1 | 2007 | 464 | 0.060 |
Why?
| Female | 5 | 2021 | 28888 | 0.060 |
Why?
| Protein Binding | 2 | 2006 | 784 | 0.060 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2004 | 252 | 0.050 |
Why?
| DNA, Plant | 1 | 2001 | 7 | 0.050 |
Why?
| Telomere | 1 | 2001 | 37 | 0.050 |
Why?
| DNA-Binding Proteins | 1 | 2004 | 507 | 0.050 |
Why?
| Models, Animal | 1 | 2021 | 267 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 50 | 0.050 |
Why?
| Nucleic Acid Conformation | 2 | 2013 | 100 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2007 | 582 | 0.050 |
Why?
| Milk, Human | 1 | 2021 | 107 | 0.050 |
Why?
| Animals, Newborn | 1 | 2021 | 402 | 0.050 |
Why?
| Swine | 1 | 2021 | 436 | 0.050 |
Why?
| Transcription Factors | 1 | 2004 | 645 | 0.050 |
Why?
| Antigens, Nuclear | 1 | 2000 | 24 | 0.050 |
Why?
| Decision Trees | 1 | 2019 | 28 | 0.050 |
Why?
| RNA, Plant | 1 | 2019 | 7 | 0.050 |
Why?
| Genes, Plant | 1 | 2019 | 11 | 0.050 |
Why?
| Symbiosis | 1 | 2019 | 9 | 0.050 |
Why?
| Gene Expression Regulation, Plant | 1 | 2019 | 37 | 0.050 |
Why?
| Li-Fraumeni Syndrome | 1 | 1999 | 14 | 0.050 |
Why?
| Exons | 1 | 1999 | 108 | 0.050 |
Why?
| Motor Neurons | 1 | 2018 | 39 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 168 | 0.040 |
Why?
| Neuroglia | 1 | 2018 | 53 | 0.040 |
Why?
| Cell Cycle | 2 | 2012 | 279 | 0.040 |
Why?
| Open Reading Frames | 2 | 2012 | 60 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 1999 | 528 | 0.040 |
Why?
| Artiodactyla | 1 | 1997 | 1 | 0.040 |
Why?
| Perissodactyla | 1 | 1997 | 1 | 0.040 |
Why?
| Electrophoresis, Agar Gel | 1 | 1997 | 12 | 0.040 |
Why?
| Random Amplified Polymorphic DNA Technique | 1 | 1997 | 5 | 0.040 |
Why?
| Spinal Cord | 1 | 2018 | 161 | 0.040 |
Why?
| Protein Isoforms | 1 | 2017 | 138 | 0.040 |
Why?
| Genetic Markers | 1 | 1997 | 124 | 0.040 |
Why?
| DNA Primers | 1 | 1997 | 242 | 0.040 |
Why?
| Time Factors | 1 | 2005 | 3434 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2000 | 1067 | 0.040 |
Why?
| Mice, Transgenic | 1 | 2018 | 725 | 0.040 |
Why?
| Phosphorylation | 1 | 2017 | 644 | 0.040 |
Why?
| MicroRNAs | 1 | 2019 | 366 | 0.040 |
Why?
| Prognosis | 1 | 2021 | 2104 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 698 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 872 | 0.030 |
Why?
| DNA Repair | 1 | 2016 | 207 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2019 | 1810 | 0.030 |
Why?
| Cell Line | 1 | 2017 | 1226 | 0.030 |
Why?
| Research Design | 1 | 2016 | 366 | 0.030 |
Why?
| Genome, Mitochondrial | 1 | 2013 | 8 | 0.030 |
Why?
| Tunica Media | 1 | 2012 | 10 | 0.030 |
Why?
| S Phase | 1 | 2012 | 19 | 0.030 |
Why?
| G1 Phase | 1 | 2012 | 19 | 0.030 |
Why?
| Lod Score | 1 | 2012 | 7 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 85 | 0.030 |
Why?
| Genes, Insect | 1 | 2012 | 12 | 0.030 |
Why?
| Larva | 1 | 2012 | 23 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 32 | 0.030 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2013 | 82 | 0.030 |
Why?
| Microarray Analysis | 1 | 2012 | 85 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 211 | 0.030 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 100 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2012 | 147 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 2003 | 105 | 0.030 |
Why?
| Internet | 1 | 2012 | 302 | 0.020 |
Why?
| Prostatic Neoplasms | 1 | 2013 | 413 | 0.020 |
Why?
| Mitochondria | 1 | 2013 | 475 | 0.020 |
Why?
| Virion | 1 | 2008 | 20 | 0.020 |
Why?
| Glioma | 1 | 2008 | 73 | 0.020 |
Why?
| Breast | 1 | 2008 | 92 | 0.020 |
Why?
| Cells, Cultured | 1 | 2012 | 1842 | 0.020 |
Why?
| DNA, Complementary | 1 | 2008 | 158 | 0.020 |
Why?
| Recombination, Genetic | 1 | 2008 | 114 | 0.020 |
Why?
| Aspartic Acid | 1 | 2007 | 48 | 0.020 |
Why?
| Age of Onset | 1 | 2007 | 121 | 0.020 |
Why?
| Centrosome | 1 | 2006 | 12 | 0.020 |
Why?
| Chromosome Segregation | 1 | 2006 | 11 | 0.020 |
Why?
| Glutamic Acid | 1 | 2007 | 112 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2006 | 195 | 0.020 |
Why?
| Spores, Bacterial | 1 | 2005 | 12 | 0.020 |
Why?
| Bacillus anthracis | 1 | 2005 | 11 | 0.020 |
Why?
| Bacillus subtilis | 1 | 2005 | 17 | 0.020 |
Why?
| Glutamine | 1 | 2007 | 171 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 299 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2005 | 71 | 0.020 |
Why?
| Arginine | 1 | 2007 | 188 | 0.020 |
Why?
| Brain Neoplasms | 1 | 2008 | 257 | 0.020 |
Why?
| Genotype | 1 | 2007 | 636 | 0.020 |
Why?
| Tyrosine Decarboxylase | 1 | 2004 | 1 | 0.020 |
Why?
| Hybridization, Genetic | 1 | 2004 | 9 | 0.020 |
Why?
| Heat Stress Disorders | 1 | 2004 | 17 | 0.020 |
Why?
| Locus Control Region | 1 | 2003 | 1 | 0.020 |
Why?
| Terminal Repeat Sequences | 1 | 2003 | 7 | 0.020 |
Why?
| False Positive Reactions | 1 | 2002 | 71 | 0.010 |
Why?
| Trinucleotide Repeats | 1 | 2002 | 4 | 0.010 |
Why?
| Codon, Initiator | 1 | 2002 | 9 | 0.010 |
Why?
| Introns | 1 | 2002 | 49 | 0.010 |
Why?
| Genome, Human | 1 | 2003 | 129 | 0.010 |
Why?
| Cohort Studies | 1 | 2007 | 1532 | 0.010 |
Why?
| Survival Analysis | 1 | 2004 | 791 | 0.010 |
Why?
| Sex Factors | 1 | 2004 | 813 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 2447 | 0.010 |
Why?
| Prospective Studies | 1 | 2007 | 2453 | 0.010 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 46 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2002 | 274 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 564 | 0.010 |
Why?
| Brain | 1 | 2008 | 1458 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2007 | 3624 | 0.010 |
Why?
| Risk Factors | 1 | 2007 | 3984 | 0.010 |
Why?
| Aged | 1 | 2007 | 10428 | 0.010 |
Why?
| Middle Aged | 1 | 2007 | 13614 | 0.010 |
Why?
| Adult | 1 | 2007 | 14316 | 0.010 |
Why?
|
|
Glazko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|